A Phase 1b Multiple Oral Dose Study to Evaluate the Pharmacological Effect, Safety and Tolerability of ASP0367 in Participants with Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate ASP0367 in participants with reduced maximum oxygen uptake due to poor systemic oxygen extraction? Contact us by filling our your information to the right and we’ll respond to you.
Brigham and Women's Hospital
Boston, United States, 02115